VEGF/VEGFR2 signaling promotes metastatic spread to secondary organs by inducing vessel permeability (4), facilitating invasion of tumor cells into metastatic tissues through augmenting expression of MMPs such as MMP9 that degrade the ECM (5). The gene discussed is KDR; the disease is neoplasm.